Costs of herpes zoster complications in older adults: A cohort study of US claims database

Abstract

Approximately 10% of immunocompetent older patients with HZ develop complications which considerably increase the economic burden of HZ. Vaccination of older adults will offset some of the burden of HZ, including costs associated with HZ-related complications.